$166.31
Price
$10.1B
Market Cap
—
P/E Ratio
7.9
Forward P/E
$-6.15
EPS (TTM)
—
Dividend Yield
$2.0B
Cash
$6.2B
Total Debt
61M
Shares Out
$95.49
$182.99
52-Week Range
Institutional Ownership of JAZZ PHARMACEUTICALS PLC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for JAZZ PHARMACEUTICALS PLC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for JAZZ PHARMACEUTICALS PLC
6 Months Insider Sentiment
Buy $0
Sell $23.1M
0
Buys
19
Sells
-23.1M
Net
1
Grants
Largest
$9.5M
Cozadd
$6.8M
Cozadd
$5.4M
Cozadd
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 09, 2025 | Mary Elizabeth Henderson | SVP, Technical Operations | SELL | 2.2K | $169.51 | $379K |
| Dec 05, 2025 | Patricia Carr | SVP, Chief Accounting Officer | SELL | 4.5K | $171.20 | $770K |
| Dec 05, 2025 | Patricia Carr | SVP, Chief Accounting Officer | SELL | 160 | $171.11 | $27K |
| Dec 05, 2025 | Patricia Carr | SVP, Chief Accounting Officer | EXERCISE | 4.5K | $140.67 | $633K |
| Nov 26, 2025 | Bruce C Cozadd | Director | SELL | 30.5K | $178.06 | $5.4M |
| Nov 26, 2025 | Bruce C Cozadd | Director | SELL | 507 | $179.79 | $91K |
| Nov 26, 2025 | Bruce C Cozadd | Director | SELL | 8.4K | $179.23 | $1.5M |
| Nov 26, 2025 | Bruce C Cozadd | Director | SELL | 38.1K | $177.27 | $6.8M |
| Nov 26, 2025 | Bruce C Cozadd | Director | EXERCISE | 811 | $123.36 | $100K |
| Nov 26, 2025 | Bruce C Cozadd | Director | EXERCISE | 76.7K | $123.36 | $9.5M |
| Nov 20, 2025 | Heather Ann Mcsharry | Director | EXERCISE | 3.4K | $138.08 | $472K |
| Nov 20, 2025 | Heather Ann Mcsharry | Director | SELL | 3.4K | $177.78 | $607K |
| Nov 20, 2025 | Bruce C Cozadd | Director | GRANT | 2.5K | — | — |
| Nov 18, 2025 | Bruce C Cozadd | Director | SELL | 717 | $182.60 | $131K |
| Nov 18, 2025 | Bruce C Cozadd | Director | SELL | 5.5K | $181.81 | $1.0M |
| Nov 18, 2025 | Bruce C Cozadd | Director | SELL | 8.4K | $180.88 | $1.5M |
| Nov 18, 2025 | Rick E Winningham | Director | SELL | 5.5K | $180.86 | $995K |
| Nov 18, 2025 | Patricia Carr | SVP, Chief Accounting Officer | EXERCISE | 5.2K | $136.18 | $715K |
| Nov 18, 2025 | Patricia Carr | SVP, Chief Accounting Officer | SELL | 69 | $181.66 | $13K |
| Nov 18, 2025 | Patricia Carr | SVP, Chief Accounting Officer | SELL | 5.2K | $182.07 | $956K |
| Nov 18, 2025 | Bruce C Cozadd | Director | SELL | 3.4K | $180.09 | $609K |
| Nov 17, 2025 | Robert Iannone | EVP, Global Head of R&D & CMO | SELL | 7.2K | $168.26 | $1.2M |
| Oct 03, 2025 | Bruce C Cozadd | Director | SELL | 3.5K | $140.00 | $490K |
| Oct 01, 2025 | Bruce C Cozadd | Director | SELL | 2.0K | $131.78 | $264K |
| Sep 02, 2025 | Bruce C Cozadd | Director | SELL | 3.0K | $127.23 | $382K |